Allergan posts loss as it writes down Teva holdings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Teva Pharma (TEVA) Sees Active Put Buying Ahead of Earnings Announcement Tomorrow BMC -Susquehanna
May 10, 2017 2:29 PM EDTSusquehanna options strategist Alison Edwards notes protective or bearish activity in Teva Pharma (NYSE: TEVA), as investors purchased ~9000 June 30 Puts and ~2000 May12 30 Puts today, ahead of the company's earnings report tomorrow before the market open.
